Abstract
CACI International Inc will report fiscal first-quarter 2027 results on October 22, 2026 Post-Mkt, with consensus pointing to revenue of 2.52 billion US dollars and adjusted EPS of 6.69 as investors gauge award conversion, margin mix, and mission-technology momentum.Market Forecast
The market now expects CACI International Inc to deliver fiscal Q1 2027 revenue of 2.52 billion US dollars, up 11.60% year over year, EBIT of 212.73 million US dollars, up 12.39% year over year, and adjusted EPS of 6.69, up 8.55% year over year; no explicit quarterly gross margin or net margin guidance has been indicated. The company’s core customer base remains concentrated in U.S. national-security and federal missions, where higher-value mission technology continues to lift mix and pipeline quality, supporting sustainable mid-teens EBIT growth relative to revenue. The most promising growth vector is mission technology across electronic warfare, space, and counter–UAS, underpinned by last quarter’s 1.51 billion US dollars of revenue from Department of Defense programs and a 29.00% year-over-year increase in funded backlog that supports accelerated conversion in the year ahead.Last Quarter Review
In fiscal Q4 2026, CACI International Inc reported revenue of 2.71 billion US dollars (up 17.57% year over year), a gross profit margin of 33.72%, GAAP net profit attributable to shareholders of 157.00 million US dollars with a net profit margin of 5.79%, and adjusted EPS of 8.91 (up 6.07% year over year). A standout financial highlight was the improvement in award flow and visibility: funded backlog rose 29.00% year over year and submitted bids under evaluation expanded to 11.00 billion US dollars, reinforcing top-line momentum into fiscal Q1. By customer category, Department of Defense programs remained the primary revenue driver at 1.51 billion US dollars (55.60% of last quarter’s total), followed by the Intelligence Community at 634.10 million US dollars (23.41%), Federal Civilian Agencies at 436.99 million US dollars (16.13%), and Commercial and Other at 131.62 million US dollars (4.86%), with continuing mix shift toward mission technology underpinning profitability resilience as total revenue increased 17.57% year over year.Current Quarter Outlook
Main business drivers: award conversion, mix, and disciplined execution
For fiscal Q1 2027, CACI International Inc enters the quarter with positive momentum from recently secured, high-value programs and an expanded opportunity set under evaluation. The near-term setup centers on converting a robust pipeline into funded revenue, with consensus modeling 11.60% year-over-year growth to 2.52 billion US dollars and adjusted EPS of 6.69. Execution quality should be supported by the company’s strong delivery track record and consistent focus on program risk management, which historically tempers cost overruns and sustains a healthy gross margin baseline. While the company has not provided explicit quarterly margin guidance, last quarter’s 33.72% gross profit margin provides a reference point; the mix of higher-value mission technology is a constructive offset to typical contract start-up inefficiencies that can appear early in the fiscal year. The appointment of a new chief operating officer, Dr. Dave Young, adds operational bandwidth to scale complex programs and sustain delivery amid elevated award activity; investors will pay close attention to management commentary on ramp cadence and staffing to assess the durability of outperformance. With EBIT estimated at 212.73 million US dollars, up 12.39% year over year, the operating line should benefit from both top-line growth and a favorable program mix, albeit offset in part by ongoing investments in talent and technology required to execute newly won tasks at pace.CACI International Inc’s customer set remains diversified across national-security and federal civil missions, which helps smooth quarter-to-quarter variability in project timing. Within this base, the Department of Defense remains the anchor of quarterly revenue at 1.51 billion US dollars last quarter, complemented by the Intelligence Community at 634.10 million US dollars, together accounting for roughly four-fifths of the portfolio. That blend provides multiple avenues for quarterly growth—both through modernization awards and through technical refresh cycles on existing programs—enabling the company to target low double-digit revenue growth while keeping an eye on cash conversion as contract ramps mature. Investors should expect management to emphasize disciplined capture and risk controls, with a focus on margins and schedule adherence as key differentiators in securing follow-on work. The health of the backlog and the conversion pace into funded revenue will be central to whether CACI International Inc can sustain or exceed the 11.60% revenue growth implied for fiscal Q1.
Mission technology momentum: electronic warfare, space, and counter–UAS as upside catalysts
The most promising area within CACI International Inc’s portfolio continues to be mission technology spanning electronic warfare (EW), space, and counter–UAS, which the company and covering analysts identify as higher-margin and strategically important growth vectors. Recent program wins illustrate this momentum: CACI International Inc was selected among a small group of providers to deliver technologies under the National Space Test and Training Complex Innovative Technology & Engineering – Space Test and Range framework, which could support multi-year capability development and training operations. The company also highlighted a meaningful classified counter-space award associated with the ARKA acquisition, which analysts view as a proof point for acquisition synergies and a driver of higher-value mix. In addition, a 500.00 million US dollars counter–UAS IDIQ provides a scalable pathway to revenues as orders are issued, with early tasking named and aligned to current operational needs.These awards underpin the case for above-average growth within mission technology relative to the broader portfolio. While segment-level year-over-year revenue growth rates were not disclosed, the underlying demand signal is visible through the 29.00% year-over-year increase in funded backlog reported last quarter, which indicates traction in booking and sustaining high-end technical programs. For the upcoming quarter, investors should watch for updates on program ramp schedules, early performance milestones, and any commentary on manufacturing or integration throughput where applicable, as these details can inform the durability of margin uplift tied to the mission-technology mix. A higher concentration of mission technology contributes to operating leverage via better gross margins, yet it also necessitates ongoing investment in engineering talent and specialized infrastructure; tracking hiring, retention, and subcontractor utilization will help gauge whether anticipated margin benefits can be realized within fiscal Q1 and across fiscal 2027.
The Intelligence Community and Department of Defense customer categories, which together generated approximately 2.14 billion US dollars last quarter, are natural homes for these mission-technology capabilities. As a result, the company’s most promising opportunities are not confined to a single contract, but rather span a portfolio of programs with different award dates and ramp profiles. That diversification limits the risk of any single program driving disproportionate quarter-to-quarter volatility while still allowing the company to harvest margin uplift from cumulative mix improvement. If management confirms steady progress on these programs and points to sustained demand for EW, space test and training, and counter–UAS, investors could gain confidence that EBIT growth can remain modestly above revenue growth this quarter and beyond.
What will move the stock this quarter: growth quality, margins, and cash
For fiscal Q1, the variables most likely to influence the stock are the quality of organic revenue growth relative to the 11.60% consensus, the degree of margin stability versus last quarter’s 33.72% gross profit margin, and the strength of operating cash dynamics. Growth quality will be judged by the composition of revenue—how much stems from new, higher-value awards versus lower-margin staff augmentation or lower-tech content—and by the visibility implied in the quarter-end backlog and book-to-bill. Investors will parse management’s commentary for signals on whether mission technology is scaling as planned and whether onboarding and supply-chain conditions are supportive of timely delivery. Even absent explicit quarterly margin guidance, confirmation that mix remains favorable and that programs are tracking to plan would reduce the risk of gross margin slippage and could lend support to the 212.73 million US dollars EBIT estimate.Cash generation also matters. Seasonal factors can influence fiscal Q1 free cash flow, but strong invoicing and milestone completion on larger technology programs could partially offset typical first-quarter working-capital patterns. Any update on cash conversion expectations for fiscal 2027 will be closely watched, as several analysts have emphasized free cash flow as a key part of the equity narrative. On the cost side, wage inflation and talent availability remain practical considerations for execution; evidence of successful recruiting and retention, coupled with productivity initiatives, can help preserve operating leverage and defend the adjusted EPS trajectory toward the 6.69 consensus. Finally, corporate actions—such as portfolio pruning, incremental tuck-in M&A to fortify high-end capabilities, or capital return—could add nuance to the outlook; however, the central determinant this quarter remains the consistency of award conversion and the margin profile of delivered work.
Operationally, leadership additions can also influence investor perception of near-term execution. The elevation of Dr. Dave Young to chief operating officer adds a senior operator with deep experience in complex program delivery, which could facilitate earlier identification of schedule risks and capacity needs as the company scales mission technology. If management pairs that operational rigor with sustained capture discipline—prioritizing pursuits that best align with core technologies and where pricing reflects value creation—the company can better support both margin durability and cash conversion. Updates on the cadence of task-order awards under recently won IDIQs, and clarity on near-term tasking in space test and training, will fill in the near-term revenue picture and may inform whether the quarter skews toward or above the modeled 2.52 billion US dollars.
Analyst Opinions
Bullish vs. bearish ratio over the past six months skews decisively positive, with a clear majority of Buy recommendations relative to negative calls; only the bullish side is analyzed below.- Truist Financial (Buy, 800 US dollars price target): The firm reiterates CACI International Inc as a top pick following fiscal Q4 results that showed a 29.00% year-over-year increase in funded backlog and a sharp rise in submitted bids under evaluation to 11.00 billion US dollars. Truist highlights above-Street fiscal 2027 guidance and argues that the portfolio’s mix shift toward higher-margin mission technology—specifically electronic warfare and space—supports a premium earnings multiple. The analyst also points to early validation of the ARKA acquisition via a classified counter-space award, bolstering confidence in both growth and margin trajectories. For the coming quarter, Truist’s framework implies that if award conversion remains healthy and mix continues to tilt toward mission technology, adjusted EPS can track or beat the 6.69 consensus while supporting the 11.60% revenue growth outlook.
- William Blair (Outperform/Buy): The analyst underscores the significance of recent counter-space wins and the broadening of advanced defense-and-space capabilities as key pillars of the investment case. In their view, these technical wins are not isolated; they signal differentiated competency that can translate into a steady flow of higher-value tasks. Entering fiscal Q1, William Blair’s constructive stance leans on visible demand in priority missions and the company’s consistency in execution, which together reduce the risk of downside variance versus the 2.52 billion US dollars revenue consensus. As mission technology ramps, the firm expects EBIT growth to run modestly ahead of revenue growth—consistent with the 12.39% year-over-year EBIT estimate.
- TD Cowen (Buy, 700 US dollars price target): TD Cowen maintains a positive view, citing sustained momentum in awards and healthy end demand indicators for the company’s core solutions. Heading into fiscal Q1, the firm sees a supportive backdrop for the 11.60% revenue growth estimate, with the quarterly print potentially defined by updates on mix and program ramp progress. TD Cowen’s target assumes continued operating discipline and mix-driven margin support, which are consistent with last quarter’s 33.72% gross margin baseline and a favorable EBIT growth profile relative to revenue.
- Cantor Fitzgerald (Buy, 675 US dollars price target): Cantor reaffirms a constructive stance grounded in the company’s improving growth profile, embedded visibility, and ongoing shift toward higher-value mission technology. The firm expects steady award conversion and resilient margins, and it frames the quarter as an opportunity for management to highlight execution milestones on recent wins. For fiscal Q1, Cantor’s lens suggests limited downside to consensus if backlog conversion and staffing are tracking plan, with upside if ramp timelines accelerate or tasking under newly won IDIQs arrives earlier than modeled.
- UBS (Buy; target adjusted to 804 US dollars in recent months): UBS’s higher target reflects confidence in medium-term earnings power underpinned by the company’s technology-rich mix and strong capture. UBS emphasizes that the award cadence and backlog strength provide a durable base for double-digit revenue growth and sustained EBIT leverage. Relative to this quarter, the firm will likely focus on how the company is pacing against the 212.73 million US dollars EBIT estimate and whether management’s commentary supports the view of incremental margin expansion as mission technology scales.
Across these institutions, the common bullish thread is clear: a constructive starting backlog, expanding opportunity set in technology-rich programs, and a track record of delivery that increases confidence in the 11.60% revenue growth and 6.69 adjusted EPS estimates for the quarter. The incremental debate among bullish voices is less about demand and more about pacing—how quickly recently won awards translate into funded revenue and at what margin. If management communicates steady ramp progress, stable program performance metrics, and continued success in staffing critical roles, the majority view anticipates that results should land at or modestly ahead of consensus on both revenue and EBIT. Additionally, many bullish analysts will parse any commentary on free cash conversion and capital deployment (including potential incremental M&A to deepen mission-technology capabilities) as secondary validators of the medium-term thesis.
In sum, the predominant institutional stance frames fiscal Q1 as a checkpoint on execution rather than a shifting of the narrative. With consensus anchored at 2.52 billion US dollars of revenue and 212.73 million US dollars of EBIT, and adjusted EPS of 6.69, the upside case in the near term depends on the pace of award conversion, the persistence of favorable mix, and operating discipline that preserves margin. The combination of last quarter’s 17.57% top-line growth, 33.72% gross margin baseline, and a 29.00% increase in funded backlog furnishes a credible runway, which is why the balance of published opinions remains skewed toward the Buy camp heading into the print on October 22, 2026 Post-Mkt.
Comments